• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃的肠化生可逆吗?

Is intestinal metaplasia of the stomach reversible?

作者信息

Walker M M

机构信息

Department of Histopathology, Imperial College of Science, Technology and Medicine, London, UK.

出版信息

Gut. 2003 Jan;52(1):1-4. doi: 10.1136/gut.52.1.1.

DOI:10.1136/gut.52.1.1
PMID:12477745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1773527/
Abstract

Intestinal metaplasia (IM) of the stomach is a risk factor in developing intestinal-type gastric cancer and hence the question of reversibility is vital. There is emerging epidemiological evidence that with long term follow up, IM may be reversible although a combination of antioxidant agents and eradication of H pylori may be necessary to achieve this. The pathogenesis of IM is currently being elucidated and it is likely that a combination of bacterial, host, and environmental factors will be shown to lead to IM. In assessing gastric cancer risk, histochemical typing of IM will most probably be replaced by molecular markers.

摘要

胃的肠化生(IM)是发生肠型胃癌的一个危险因素,因此其可逆性问题至关重要。新出现的流行病学证据表明,经过长期随访,IM可能是可逆的,不过可能需要联合使用抗氧化剂并根除幽门螺杆菌才能实现这一点。IM的发病机制目前正在阐明,很可能是细菌、宿主和环境因素共同作用导致IM。在评估胃癌风险时,IM的组织化学分型很可能会被分子标志物所取代。

相似文献

1
Is intestinal metaplasia of the stomach reversible?胃的肠化生可逆吗?
Gut. 2003 Jan;52(1):1-4. doi: 10.1136/gut.52.1.1.
2
Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori.伴有和不伴有肠化生的胃黏膜中CDX2的异常表达:根除幽门螺杆菌的影响
Helicobacter. 2002 Jun;7(3):192-8. doi: 10.1046/j.1523-5378.2002.00080.x.
3
Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer.随机临床试验:胃癌胃大部切除术后幽门螺杆菌根除对腺体萎缩和肠上皮化生的影响。
Aliment Pharmacol Ther. 2013 Sep;38(5):477-89. doi: 10.1111/apt.12402. Epub 2013 Jul 3.
4
Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.胃发育异常的化学预防:抗氧化剂补充剂与抗幽门螺杆菌治疗的随机试验
J Natl Cancer Inst. 2000 Dec 6;92(23):1881-8. doi: 10.1093/jnci/92.23.1881.
5
H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.幽门螺杆菌根除可预防反流性食管炎患者使用长期埃索美拉唑后胃小肠化生的进展。
Am J Gastroenterol. 2009 Jul;104(7):1642-9. doi: 10.1038/ajg.2009.172. Epub 2009 May 12.
6
Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer.幽门螺杆菌根除可预防肠化生扩展,即使在胃癌高危人群中也是如此。
Digestion. 2010;81(4):223-30. doi: 10.1159/000264651. Epub 2010 Jan 29.
7
Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis.分析胃化生对无萎缩性胃炎的幽门螺杆菌感染患者胃溃疡愈合的影响。
BMC Gastroenterol. 2017 Jan 3;17(1):1. doi: 10.1186/s12876-016-0563-8.
8
Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.在不完全肠化生之前根除幽门螺杆菌后,音猬因子的重新表达及CDX2的减少。
Int J Cancer. 2007 Sep 15;121(6):1182-9. doi: 10.1002/ijc.22835.
9
Determinants of gastric CDX2 expression: a study in Mozambique.胃 CDX2 表达的决定因素:莫桑比克的一项研究。
Eur J Cancer Prev. 2012 Nov;21(6):532-40. doi: 10.1097/CEJ.0b013e3283523480.
10
Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.幽门螺杆菌相关的胃黏膜肠化生:治疗与监测
World J Gastroenterol. 2016 Jan 21;22(3):1311-20. doi: 10.3748/wjg.v22.i3.1311.

引用本文的文献

1
A Novel tRF, HCETSR, Derived From tRNA-Glu/TTC, Inhibits HCC Malignancy by Regulating the SPBTN1-catenin Complex Axis.一种源自tRNA-Glu/TTC的新型tRF,即HCETSR,通过调节SPBTN1-连环蛋白复合体轴抑制肝癌恶性进展。
Adv Sci (Weinh). 2025 Apr;12(13):e2415229. doi: 10.1002/advs.202415229. Epub 2025 Feb 8.
2
Intestinal Metaplasia Associated with Symptoms of Dyspepsia.与消化不良症状相关的肠化生
Res Sq. 2023 Oct 3:rs.3.rs-3335631. doi: 10.21203/rs.3.rs-3335631/v1.
3
Epithelial cell plasticity: breaking boundaries and changing landscapes.上皮细胞可塑性:突破边界,改变格局。
EMBO Rep. 2021 Jul 5;22(7):e51921. doi: 10.15252/embr.202051921. Epub 2021 Jun 6.
4
Molecular Alterations in Gastric Intestinal Metaplasia.胃肠上皮化生的分子改变。
Int J Mol Sci. 2021 May 28;22(11):5758. doi: 10.3390/ijms22115758.
5
Molecular alterations in gastric cancer and the surrounding intestinal metaplastic mucosa: an analysis of isolated glands.胃癌及周围肠上皮化生黏膜中分子改变的研究:孤立腺分析。
Gastric Cancer. 2021 Mar;24(2):382-391. doi: 10.1007/s10120-020-01130-z. Epub 2020 Nov 3.
6
Translation of gastric disease progression at gene level expression.基因水平表达下胃部疾病进展的翻译
J Cancer. 2020 Jan 1;11(2):520-532. doi: 10.7150/jca.29038. eCollection 2020.
7
Change of the duodenal mucosa-associated microbiota is related to intestinal metaplasia.十二指肠黏膜相关菌群的变化与肠上皮化生有关。
BMC Microbiol. 2019 Dec 9;19(1):275. doi: 10.1186/s12866-019-1666-5.
8
Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA.美国胃肠上皮化生诊断与管理的最新进展。
Dig Dis Sci. 2019 May;64(5):1079-1088. doi: 10.1007/s10620-019-05526-5.
9
Modulating Cell Fate as a Therapeutic Strategy.调控细胞命运作为一种治疗策略。
Cell Stem Cell. 2018 Sep 6;23(3):329-341. doi: 10.1016/j.stem.2018.05.009. Epub 2018 Jun 14.
10
Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.瑞巴派特对慢性胃炎癌前病变进展的影响:一项随机对照研究。
Clin Drug Investig. 2015 Oct;35(10):665-73. doi: 10.1007/s40261-015-0329-z.

本文引用的文献

1
Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.幽门螺杆菌根除治疗可改善萎缩性胃炎和肠化生:一项针对萎缩性胃炎患者的5年前瞻性研究。
Aliment Pharmacol Ther. 2002 Aug;16(8):1449-56. doi: 10.1046/j.1365-2036.2002.01311.x.
2
Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia.幽门螺杆菌毒力基因与宿主白细胞介素-1受体拮抗剂(IL-1RN)基因和白细胞介素-1β(IL-1β)基因相互作用,促进消化性溃疡和肠化生的发展。
Cytokine. 2002 Jun 7;18(5):242-51. doi: 10.1006/cyto.2002.0891.
3
Review article: intestinal metaplasia and gastric carcinogenesis.综述文章:肠化生与胃癌发生
Aliment Pharmacol Ther. 2002 Jul;16(7):1209-16. doi: 10.1046/j.1365-2036.2002.01300.x.
4
Cyclooxygenase-2 and Bcl-2 expression in the stomach mucosa of Wistar rats exposed to Helicobacter pylori, N'-methyl- N'-nitro- N-nitrosoguanidine and bile.幽门螺杆菌、N'-甲基-N'-硝基-N-亚硝基胍和胆汁作用下Wistar大鼠胃黏膜中环氧化酶-2和Bcl-2的表达
Virchows Arch. 2002 Jul;441(1):77-84. doi: 10.1007/s00428-001-0571-z. Epub 2001 Dec 18.
5
Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori.伴有和不伴有肠化生的胃黏膜中CDX2的异常表达:根除幽门螺杆菌的影响
Helicobacter. 2002 Jun;7(3):192-8. doi: 10.1046/j.1523-5378.2002.00080.x.
6
How cells change their phenotype.细胞如何改变其表型。
Nat Rev Mol Cell Biol. 2002 Mar;3(3):187-94. doi: 10.1038/nrm761.
7
Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings.关于幽门螺杆菌感染与萎缩性胃炎进展之间关系的十年前瞻性随访研究,特别是通过内镜检查结果进行评估。
Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:198-203. doi: 10.1046/j.1365-2036.16.s2.13.x.
8
Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis.普通人群及自身免疫性慢性萎缩性胃炎患者肠化生亚型的患病率。
Scand J Gastroenterol. 2002 Mar;37(3):262-6. doi: 10.1080/003655202317284156.
9
Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia.在肠化生进展过程中,同源框基因CDX2的表达先于CDX1。
J Gastroenterol. 2002;37(2):94-100. doi: 10.1007/s005350200002.
10
Key molecules in metaplastic gastritis: sequential analysis of CDX1/2 homeobox gene expression.化生型胃炎中的关键分子:CDX1/2 同源框基因表达的序列分析
J Gastroenterol. 2002;37(2):147-8. doi: 10.1007/s005350200013.